Institutional shares held 1.93 Million
0 calls
0 puts
Total value of holdings $20M
$0 calls
$0 puts
Market Cap $151M
14,642,500 Shares Out.
Institutional ownership 13.2%
# of Institutions 32


Latest Institutional Activity in NVCT

Top Purchases

Q1 2025
Oppenheimer & CO Inc Shares Held: 41K ($424K)
Q1 2025
Blue Zone Wealth Advisors, LLC Shares Held: 10.4K ($108K)
Q1 2025
Baldwin Brothers LLC Shares Held: 358K ($3.7M)
Q4 2024
Marshall Wace, LLP Shares Held: 125K ($1.29M)
Q4 2024
Vanguard Group Inc Shares Held: 325K ($3.36M)

Top Sells

Q4 2024
Millennium Management LLC Shares Held: 29.7K ($307K)
Q4 2024
Gsa Capital Partners LLP Shares Held: 34.8K ($359K)
Q4 2024
Two Sigma Investments, LP Shares Held: 18.6K ($192K)
Q4 2024
Edmond De Rothschild Holding S.A. Shares Held: 15.2K ($157K)
Q4 2024
Geode Capital Management, LLC Shares Held: 79.2K ($819K)

About NVCT

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.


Insider Transactions at NVCT

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
980K Shares
From 11 Insiders
Grant, award, or other acquisition 691K shares
Open market or private purchase 289K shares
Sell / Disposition
2.76K Shares
From 1 Insiders
Open market or private sale 2.76K shares

Track Institutional and Insider Activities on NVCT

Follow Nuvectis Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCT shares.

Notify only if
Any

Insider Trading

Get notified when an Nuvectis Pharma, Inc. insider buys or sells NVCT shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Nuvectis Pharma, Inc.

Track Activities on NVCT